Morgan Stanley IM’s Dennis Lynch on AI: “There is no clear winner”
Dennis Lynch, who heads up some of Morgan Stanley IM’s top-performing growth equity strategies, shares with FSA his thoughts on artificial intelligence and investing in the face of volatility.
RQI Investors brings flagship quant value strategy to Singapore, UK, Europe and Canada
The new UCITS vehicle has secured $20m in seed funding from a family office and $30m from its parent First Sentier Investors.
JPMAM backs a high income equity strategy
A high income-oriented global equity portfolio has historically generated extra income with less volatility, says JP Morgan’s Sam Witherow.
5 funds that have bounced back post-tariff sell-off
FSA highlights five global equity funds that have outperformed since markets started to recover from the tariff sell-off.
Lazard AM: Navigating market shifts through quantitative equity investment
A quantitative strategy tilted toward lower valuations, higher growth and quality measures produces consistent excess returns, says Antony Creighton, director, head of strategy (Asia ex-Japan) at Lazard Asset Management.
Fidelity: Focus on high-quality dividend payers
Investors should use the “three fundamental building blocks”, says Fidelity’s Jochen Breuer.
Wellington, Vanguard and Blackstone partner to combine public-private assets
The firms aim to bring multi-asset strategies with both public and private assets to the masses.
Liontrust and AllianzGI: All eyes on AI
After a volatile start to the year, two managers discuss the outlook for the tech market.
Top-performing fund beats S&P 500 buying cheap European stocks
The Brandes European value fund has been crushing the competition, and it boils down to a fixation on price, according to the fund’s co-manager Jeffrey Germain.
ARK Invest: Is AI the wonder cure for the broken healthcare sector?
Adopting new technology could help pharma and biotech firms fix the expensive and lengthily drug development process, writes Rahul Bhushan.
Faith in equity income stocks starts to pay dividend
There are signs of a change after years of dominance by US tech with 88% of companies raising dividends or holding them steady in 2024
AllianceBernstein: Investors risk under-exposure to EM equities
The performance track record of emerging markets (EM) stocks over two decades highlights the need to stay allocated and ride inevitable market volatility, said EM equities specialist Sammy Suzuki.
Invesco upgrades ex-US equities as it stays cautious
Shifting market dynamics are leading to downward revisions in US earnings, says Invesco.
AllianceBernstein: Don’t bet on clinical trials when investing in healthcare
Most healthcare investors focus on binary bets around clinical trials instead of buying profitable healthcare businesses, according to AllianceBernstein’s Vinay Thapar.
Invesco QQQ ETF approved for sale on HKEX
It is the first cross-listing of Invesco QQQ outside of North America.
Fidelity International: This China rally is different
China holds the keys to fight its deflationary forces, rebalance its economy and create more sustainable growth domestically, according to Fidelity International’s George Efstathopoulos.
Loading…
Something went wrong. Please refresh the page and/or try again.
FSA SPY
The FSA Spy market buzz – 16 May 2025
Playing monopoly with ETFs; Eastspring is worrying about loss aversion; Family office explosion; SGX wants more action; The Fear and Greed Index; Retail investors plough on; Deepfake fraud and much more.
